How can your enterprise benefit from China's developments?
SILREAL offers a wide range of consulting services with the ultimate goal of supporting European companies expand in Chinese markets and vice-versa. Working with our clients from start to finish, we help develop new ideas, define effective strategies and implement sustainable solutions.
SILREAL leverages its profound cultural and economic expertise with its extensive network of top decision-makers in China to create a business-friendly bridge from Europe to the Middle Kingdom. A holistic consulting approach guides our work from planning to implementation, resulting in measurable success for our clients in their international business.
Contact us to learn more.
SILREAL GmbH is a specialized management consultancy with a focus on the healthcare sector in China. With in-depth knowledge of the Chinese and European health systems, insights into the latest innovative developments in healthcare and intercultural competence, SILREAL enables its customers from various health sectors to assert themselves in digitalization.
We support companies in their cooperation in market entry and expansion projects and optimally exploit the potential of the Chinese market. With consulting, seminars and interactive workshops, we provide you with many years of experience and in-depth specialist knowledge and ensure the successful implementation of your projects related to China.
Our functional expertise
Implications and forecasts of future market trends
Benchmarking and competitor analysis
Quantitative and qualitative data collection and analysis
Market entry strategy
Business plan development and innovation management
Growth and expansion strategy
Establishing partnerships, alliances and sales networks
Digitalization strategies & change management
Process and project management
4 special fields of our expertise
PHARMA & BIOTECHNOLOGIES
China is the second largest pharmaceutical market in the world after the USA. With extensive experience and in-depth knowledge of both the Chinese and European healthcare systems, we support pharmaceutical companies in opening up new markets, expanding existing business activities and building up new partnerships.
The medtech industry has developed towards one of the most diverse and innovative sectors in Europe. This dynamic development area offers a lot of potential: on the one hand for the export of business activities from China to Germany and vice versa, on the other hand also for cooperation between companies and public institutions.
Claims and offers to and for the supply of medical services have changed significantly. Online offers change quickly and offer a lot of innovation and optimization potential for companies. We support utilities in successfully implementing new processes and digitization strategies.
In order to secure the status as one of the leading export countries for health care products, many initiatives are implemented on behalf of public institutions. Here we work closely together to promote cooperation in the healthcare sector and to strengthen long-term partnerships.
SILREAL GmbH, founded by Chenchao Liu, is a management consultancy specializing in healthcare with a geographic focus on China. The core competencies lie in strategic planning, business development as well as the implementation and execution of China-related projects. With specialist knowledge in the Chinese and European health care system, intercultural skills and the early recognition of economic, political and technological developments, we support customers in expanding and entering the market on the European and Chinese side. Our expertise is valued by leading global companies from the private sector as well as by public institutions such as the Federal Ministry of Health, the Federation of German Industry and the Fraunhofer Society.
Chenchao Liu has a degree in chemistry from the Technical University of Munich, conducted research at the Max Planck Institute and the ETH Zurich and has several years of consultancy experience at the interface between the European and Chinese healthcare systems. As a global shaper of the WEF and a recognized keynote speaker, his expertise on China and health-related topics is valued by both companies in the health industry and public institutions.
Dr. Andreas Marschall has more than 30 years of professional experience in the diagnostics industry. He worked in the areas of R&D, PM, international global marketing, business development and international product management at Roche Diagnostics GmbH, for the last 10 years with a focus on Asia (China, Japan). He studied and did his doctorate in chemistry and deepened his molecular biology know-how as a postdoc at the Ludwig Maximilians University in Munich.
Chang Liu holds a Masters degree in International Relations from Johns Hopkins University and has 10 years of experience in the Chinese market research and consulting industry. Working at LEK Consulting Shanghai and Ipsos Medical as Project Director, she has a broad network and in-depth knowledge of market research, regulatory guidelines and approval procedures for pharmaceuticals, medical technology and life science products in China.